Literature DB >> 15824997

It is time to implement routine, not risk-based, HIV testing.

Curt G Beckwith1, Timothy P Flanigan, Carlos del Rio, Emma Simmons, Edward J Wing, Charles C J Carpenter, John G Bartlett.   

Abstract

Approximately one-quarter of a million persons in the United States who are infected with human immunodeficiency virus (HIV) do not know it. To decrease the number of such persons, primary care providers should make HIV testing a routine component of health care. HIV testing should also be offered routinely in other settings, such as emergency departments, jails, and substance abuse treatment centers. Currently, the Centers for Disease Control and Prevention and the Infectious Diseases Society of America recommend routine HIV testing only in settings where the prevalence of HIV infection is > or =1%; in settings where the prevalence of HIV infection is <1%, testing should be based on risk assessment. Because of the impracticality of strategies for testing that are based on estimates of prevalence, and because of the inaccuracy of risk assessment, we propose that HIV testing be routinely offered to any person who is sexually active. As an adjunct to the implementation of routine testing programs, counseling practices need to be streamlined, and rapid HIV testing needs to be implemented in the appropriate settings.

Entities:  

Mesh:

Year:  2005        PMID: 15824997     DOI: 10.1086/428620

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  29 in total

1.  Scaling up HIV prevention: why routine or mandatory testing is not feasible for sub-Saharan Africa.

Authors:  Ad Asante
Journal:  Bull World Health Organ       Date:  2007-08       Impact factor: 9.408

2.  Editorial commentary: Hepatitis C virus testing and drug use in north america; is there more than meets the eye?

Authors:  Curt G Beckwith; Sarah Larney; Timothy P Flanigan
Journal:  Clin Infect Dis       Date:  2013-12-20       Impact factor: 9.079

3.  Vouchers versus Lotteries: What works best in promoting Chlamydia screening? A cluster randomised controlled trial.

Authors:  Claudia Niza; Caroline Rudisill; Paul Dolan
Journal:  Appl Econ Perspect Policy       Date:  2014-03-01       Impact factor: 4.083

4.  UNAIDS 90-90-90 Campaign to End the AIDS Epidemic in Historic Perspective.

Authors:  Powel Kazanjian
Journal:  Milbank Q       Date:  2017-06       Impact factor: 4.911

5.  HIV self-testing among online MSM in China: implications for expanding HIV testing among key populations.

Authors:  Larry Han; Cedric H Bien; Chongyi Wei; Kathryn E Muessig; Min Yang; Fengying Liu; Ligang Yang; Gang Meng; Michael E Emch; Joseph D Tucker
Journal:  J Acquir Immune Defic Syndr       Date:  2014-10-01       Impact factor: 3.731

6.  Impact of a primary care national policy on HIV screening in France: a longitudinal analysis between 2006 and 2013.

Authors:  Jonathan Sicsic; Olivier Saint-Lary; Elisabeth Rouveix; Nathalie Pelletier-Fleury
Journal:  Br J Gen Pract       Date:  2016-09-26       Impact factor: 5.386

7.  HIV/TB co-infection in mainland China: a meta-analysis.

Authors:  Lei Gao; Feng Zhou; Xiangwei Li; Qi Jin
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

8.  Decreasing Missed Opportunities for HIV Testing in Primary Care through Enhanced Utilization of the Electronic Medical Record.

Authors:  Ann K Avery; Michelle Del Toro; Douglaus Einstadter
Journal:  J AIDS Clin Res       Date:  2012-08-26

9.  Association between testing for human immunodeficiency virus and changes in risk behaviors among injecting drug users in southern China.

Authors:  Xia Jin; Kumi Smith; Yongli Sun; Guowei Ding; Yan Yao; Junjie Xu; Dongfang Chang; Guixiang Wang; Yun Zhu; Ning Wang
Journal:  Sex Transm Dis       Date:  2009-08       Impact factor: 2.830

10.  Perceptions of tuberculosis patients on provider-initiated HIV testing and counseling--a study from south India.

Authors:  Beena E Thomas; Puneet K Dewan; Sophia Vijay; Aleyamma Thomas; Lakhdir Singh Chauhan; Chandrasekaran Vedachalam; Preetish Vaidyanathan; Soumya Swaminathan
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.